Compare WYETH with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs CADILA HEALTHCARE - Comparison Results

WYETH     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH CADILA HEALTHCARE WYETH/
CADILA HEALTHCARE
 
P/E (TTM) x 27.7 25.3 109.7% View Chart
P/BV x 5.3 4.4 120.8% View Chart
Dividend Yield % 1.3 0.8 163.4%  

Financials

 WYETH   CADILA HEALTHCARE
EQUITY SHARE DATA
    WYETH
Mar-13
CADILA HEALTHCARE
Mar-20
WYETH/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,044352 296.5%   
Low Rs818207 396.1%   
Sales per share (Unadj.) Rs298.6139.2 214.4%  
Earnings per share (Unadj.) Rs57.211.8 486.5%  
Cash flow per share (Unadj.) Rs58.418.6 314.6%  
Dividends per share (Unadj.) Rs17.003.50 485.7%  
Dividend yield (eoy) %1.81.3 145.7%  
Book value per share (Unadj.) Rs249.5101.4 246.1%  
Shares outstanding (eoy) m22.721,023.74 2.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.12.0 155.4%   
Avg P/E ratio x16.323.7 68.5%  
P/CF ratio (eoy) x15.915.0 105.9%  
Price / Book Value ratio x3.72.8 135.4%  
Dividend payout %29.729.8 99.8%   
Avg Mkt Cap Rs m21,157286,033 7.4%   
No. of employees `0000.513.4 3.7%   
Total wages/salary Rs m40024,145 1.7%   
Avg. sales/employee Rs Th13,787.410,632.7 129.7%   
Avg. wages/employee Rs Th813.01,801.2 45.1%   
Avg. net profit/employee Rs Th2,643.3898.5 294.2%   
INCOME DATA
Net Sales Rs m6,783142,531 4.8%  
Other income Rs m3531,139 31.0%   
Total revenues Rs m7,136143,670 5.0%   
Gross profit Rs m1,61724,198 6.7%  
Depreciation Rs m276,965 0.4%   
Interest Rs m63,418 0.2%   
Profit before tax Rs m1,93814,954 13.0%   
Minority Interest Rs m0288 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6323,198 19.8%   
Profit after tax Rs m1,30112,044 10.8%  
Gross profit margin %23.817.0 140.4%  
Effective tax rate %32.621.4 152.6%   
Net profit margin %19.28.5 226.9%  
BALANCE SHEET DATA
Current assets Rs m6,98487,154 8.0%   
Current liabilities Rs m2,05682,694 2.5%   
Net working cap to sales %72.63.1 2,321.7%  
Current ratio x3.41.1 322.3%  
Inventory Days Days9971 139.0%  
Debtors Days Days2494 25.5%  
Net fixed assets Rs m244133,236 0.2%   
Share capital Rs m2271,024 22.2%   
"Free" reserves Rs m5,441102,733 5.3%   
Net worth Rs m5,668103,757 5.5%   
Long term debt Rs m2532,146 0.1%   
Total assets Rs m7,901236,866 3.3%  
Interest coverage x353.35.4 6,573.4%   
Debt to equity ratio x00.3 1.4%  
Sales to assets ratio x0.90.6 142.7%   
Return on assets %16.56.5 253.2%  
Return on equity %22.911.6 197.7%  
Return on capital %34.013.7 248.0%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1552,752 0.0%   
Fx outflow Rs m2,67714,504 18.5%   
Net fx Rs m-2,66238,248 -7.0%   
CASH FLOW
From Operations Rs m92325,054 3.7%  
From Investments Rs m317-10,123 -3.1%  
From Financial Activity Rs m-481-10,942 4.4%  
Net Cashflow Rs m7593,989 19.0%  

Share Holding

Indian Promoters % 0.0 74.8 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 8.3 136.1%  
FIIs % 7.2 5.9 122.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 11.0 276.4%  
Shareholders   21,978 44,069 49.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  CIPLA  TORRENT PHARMA  

Compare WYETH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Oil Corporation Asset Monetisation Plan, MTAR and Easy Trip Planners IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed huge selling yesterday and ended their day deep in the red.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading?(Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

WYETH SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH

WYETH - ABBOTT INDIA COMPARISON

COMPARE WYETH WITH

MARKET STATS